Madrigal Pharmaceuticals Inc banner

Madrigal Pharmaceuticals Inc
NASDAQ:MDGL

Watchlist Manager
Madrigal Pharmaceuticals Inc Logo
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
Watchlist
Price: 523.69 USD -3% Market Closed
Market Cap: $12B

Wall St Price Targets

MDGL Price Targets Summary
Madrigal Pharmaceuticals Inc

Wall Street analysts forecast MDGL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDGL is 691.65 USD with a low forecast of 555.5 USD and a high forecast of 1 012.2 USD.

Lowest Forecast
Price Target
555.5 USD
6% Upside
Average Forecast
Price Target
691.65 USD
32% Upside
Highest Forecast
Price Target
1 012.2 USD
93% Upside
Madrigal Pharmaceuticals Inc Competitors:
Price Targets
MDLZ
Mondelez International Inc
13% Upside
NSIT
Insight Enterprises Inc
18% Upside
SANA
Sana Biotechnology Inc
185% Upside
SSRM
SSR Mining Inc
45% Upside
PTCT
PTC Therapeutics Inc
28% Upside
CSGP
CoStar Group Inc
58% Upside

Revenue
Forecast

102% / Year
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
102% / Year
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 102%. The projected CAGR for the next 8 years is 26%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-36%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-36%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is MDGL's stock price target?
Price Target
691.65 USD

According to Wall Street analysts, the average 1-year price target for MDGL is 691.65 USD with a low forecast of 555.5 USD and a high forecast of 1 012.2 USD.

What is the Revenue forecast for Madrigal Pharmaceuticals Inc?
Projected CAGR
26%

Over the last 13 years, the compound annual growth rate for Revenue has been 102%. The projected CAGR for the next 8 years is 26%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett